cbdMD (YCBD)
cbdMD on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on NYSE, classified by the SEC as perfumes, cosmetics & other toilet preparations.
Short interest in cbdMD (YCBD) was 482,585 shares at the 30 October 2026 settlement, down 11.6% from the 15 October 2026 settlement, with days to cover at 7.4. The next earnings report for cbdMD is estimated for 24 November 2026.
483K
Short interest
settlement 2026-10-30
7.4
Days to cover
+2.0 days vs prior
28.7%
Short share of volume
2026-11-20
7,524
Fails to deliver
settlement 2026-10-30
Tue 24 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-20.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 October 2026, short interest in YCBD is 482,585 shares, down 128,517 shares over the last month. Over the last 48 readings it ranged from 37,832 shares (15 May 2025) to 3,970,725 shares (15 December 2025). At the reported average volume of 65K shares a day that is 7.4 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/ycbd" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-30 | 482,585 | -11.6% | 65,254 | 7.40 |
| 2026-10-15 | 546,032 | -10.7% | 101,364 | 5.39 |
| 2026-09-30 | 611,102 | +19.6% | 1,561,862 | 1.00 |
| 2026-09-15 | 511,113 | -2.2% | 269,429 | 1.90 |
| 2026-08-31 | 522,467 | +5.9% | 91,552 | 5.71 |
| 2026-08-14 | 493,249 | -6.5% | 242,986 | 2.03 |
| 2026-07-31 | 527,696 | -5.9% | 203,287 | 2.60 |
| 2026-07-15 | 560,985 | +2.0% | 264,690 | 2.12 |
| 2026-06-30 | 550,098 | -7.3% | 166,088 | 3.31 |
| 2026-06-15 | 593,633 | -11.2% | 150,430 | 3.95 |
| 2026-05-29 | 668,745 | -13.3% | 211,092 | 3.17 |
| 2026-05-15 | 770,947 | -17.2% | 466,110 | 1.65 |
| 2026-04-30 | 931,108 | +188.8% | 6,453,086 | 1.00 |
| 2026-04-15 | 322,354 | -43.0% | 381,765 | 1.00 |
| 2026-03-31 | 565,468 | +2.0% | 427,653 | 1.32 |
| 2026-03-13 | 554,205 | -49.7% | 516,984 | 1.07 |
| 2026-02-27 | 1,102,343 | +5.8% | 686,489 | 1.61 |
| 2026-02-13 | 1,041,977 | +43.7% | 687,845 | 1.51 |
| 2026-01-30 | 725,021 | -3.6% | 2,936,031 | 1.00 |
| 2026-01-15 | 752,043 | -39.1% | 1,242,503 | 1.00 |
| 2025-12-31 | 1,234,477 | -68.9% | 24,116,987 | 1.00 |
| 2025-12-15 | 3,970,725 | +446.5% | 34,203,375 | 1.00 |
| 2025-11-28 | 726,585 | +443.0% | 1,993,133 | 1.00 |
| 2025-11-14 | 133,816 | -41.7% | 138,683 | 1.00 |
| 2025-10-31 | 229,562 | -42.4% | 248,112 | 1.00 |
| 2025-10-15 | 398,585 | -83.4% | 1,736,961 | 1.00 |
| 2025-09-30 | 2,405,010 | +2666.7% | 18,721,955 | 1.00 |
| 2025-09-15 | 86,928 | +1.1% | 69,595 | 1.25 |
| 2025-08-29 | 86,024 | +26.9% | 139,666 | 1.00 |
| 2025-08-15 | 67,802 | +19.4% | 123,382 | 1.00 |
| 2025-07-31 | 56,778 | +35.9% | 65,915 | 1.00 |
| 2025-07-15 | 41,796 | -35.7% | 53,553 | 1.00 |
| 2025-06-30 | 64,988 | -13.1% | 109,579 | 1.00 |
| 2025-06-13 | 74,780 | -31.3% | 82,183 | 1.00 |
| 2025-05-30 | 108,784 | +187.5% | 104,447 | 1.04 |
| 2025-05-15 | 37,832 | -95.4% | 261,328 | 1.00 |
| 2025-04-30 | 822,602 | +33.5% | 286,765 | 2.87 |
| 2025-04-15 | 616,134 | +38.8% | 2,066,793 | 1.00 |
| 2025-03-31 | 443,908 | +2.5% | 189,894 | 2.34 |
| 2025-03-14 | 432,978 | -10.7% | 443,981 | 1.00 |
| 2025-02-28 | 484,846 | +5.4% | 681,587 | 1.00 |
| 2025-02-14 | 459,839 | -17.8% | 1,292,368 | 1.00 |
| 2025-01-31 | 559,230 | +17.9% | 3,196,276 | 1.00 |
| 2025-01-15 | 474,339 | +66.4% | 6,176,628 | 1.00 |
| 2024-12-31 | 285,039 | +32.0% | 1,410,332 | 1.00 |
| 2024-12-13 | 215,920 | +11.8% | 104,480 | 2.07 |
| 2024-11-29 | 193,152 | -6.2% | 85,377 | 2.26 |
| 2024-11-15 | 205,956 | -26.6% | 210,371 | 1.00 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 20 November 2026, the short share of YCBD volume is 28.7%, down 1.5 points over the last five sessions. Over the last 30 readings it ranged from 9.8% (26 October 2026) to 84.9% (16 October 2026). The latest reading is 7.8 points below the 30-session average of 36.5%, on 72K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-20 | 21K | 72K | 28.7% | 225 |
| 2026-11-19 | 17K | 62K | 27.6% | 0 |
| 2026-11-18 | 51K | 117K | 43.8% | 100 |
| 2026-11-17 | 21K | 65K | 31.7% | 0 |
| 2026-11-16 | 19K | 82K | 23.6% | 0 |
| 2026-11-13 | 68K | 225K | 30.2% | 500 |
| 2026-11-12 | 16K | 41K | 39.4% | 0 |
| 2026-11-11 | 9K | 14K | 60.7% | 0 |
| 2026-11-10 | 11K | 42K | 27.4% | 0 |
| 2026-11-09 | 28K | 90K | 30.6% | 0 |
| 2026-11-06 | 14K | 28K | 50.5% | 0 |
| 2026-11-05 | 23K | 40K | 57.8% | 0 |
| 2026-11-04 | 29K | 130K | 22.0% | 0 |
| 2026-11-03 | 56K | 138K | 40.8% | 0 |
| 2026-11-02 | 45K | 165K | 27.0% | 0 |
| 2026-10-30 | 6K | 26K | 23.5% | 0 |
| 2026-10-29 | 58K | 120K | 48.2% | 200 |
| 2026-10-28 | 11K | 22K | 52.3% | 0 |
| 2026-10-27 | 4K | 15K | 24.9% | 0 |
| 2026-10-26 | 2K | 25K | 9.8% | 0 |
| 2026-10-23 | 1K | 8K | 14.2% | 0 |
| 2026-10-22 | 2K | 7K | 33.9% | 0 |
| 2026-10-21 | 4K | 28K | 14.0% | 600 |
| 2026-10-20 | 11K | 27K | 42.6% | 2 |
| 2026-10-19 | 9K | 16K | 58.1% | 0 |
| 2026-10-16 | 37K | 43K | 84.9% | 0 |
| 2026-10-15 | 10K | 47K | 21.9% | 0 |
| 2026-10-14 | 31K | 71K | 44.7% | 0 |
| 2026-10-13 | 35K | 90K | 38.9% | 0 |
| 2026-10-12 | 31K | 75K | 41.1% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 30 October 2026, the fails-to-deliver balance in YCBD is 7,524 shares, up 7,185 shares over the last settlement date. Over the last 30 readings it ranged from 97 shares (27 July 2026) to 68,968 shares (22 September 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-30 | 7,524 | $0.39 | $3K |
| 2026-10-26 | 339 | $0.36 | $122 |
| 2026-10-23 | 406 | $0.37 | $150 |
| 2026-10-21 | 7,805 | $0.39 | $3K |
| 2026-09-22 | 68,968 | $0.44 | $30K |
| 2026-09-21 | 4,712 | $0.45 | $2K |
| 2026-09-18 | 5,965 | $0.50 | $3K |
| 2026-09-04 | 161 | $0.48 | $77 |
| 2026-09-01 | 10,298 | $0.49 | $5K |
| 2026-08-31 | 1,451 | $0.50 | $726 |
| 2026-08-26 | 2,203 | $0.52 | $1K |
| 2026-08-24 | 129 | $0.51 | $66 |
| 2026-08-14 | 789 | $0.57 | $450 |
| 2026-08-12 | 10,820 | $0.59 | $6K |
| 2026-08-11 | 6,749 | $0.57 | $4K |
| 2026-08-07 | 4,015 | $0.57 | $2K |
| 2026-08-04 | 4,281 | $0.57 | $2K |
| 2026-07-27 | 97 | $0.54 | $52 |
| 2026-07-17 | 1,821 | $0.62 | $1K |
| 2026-07-16 | 1,170 | $0.64 | $749 |
| 2026-07-14 | 9,630 | $0.68 | $7K |
| 2026-07-09 | 5,278 | $0.75 | $4K |
| 2026-07-07 | 346 | $0.71 | $246 |
| 2026-06-25 | 4,345 | $0.66 | $3K |
| 2026-06-24 | 3,556 | $0.67 | $2K |
| 2026-06-23 | 4,131 | $0.69 | $3K |
| 2026-06-22 | 13,399 | $0.72 | $10K |
| 2026-06-15 | 776 | $0.69 | $535 |
| 2026-06-12 | 9,253 | $0.70 | $6K |
| 2026-06-11 | 2,269 | $0.69 | $2K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for YCBD in the last 90 days. The most recent filings are listed below. Latest filing: Swift Sibyl Nichole (Director) on 2026-04-14.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-04-14 | Swift Sibyl Nichole | Director | Grant | 2K | $0.00 | $0 | 4K |
| 2026-04-14 | Stephen Scott G. | Director | Grant | 2K | $0.00 | $0 | 4K |
| 2026-04-14 | Sellers Bakari T. | Director | Grant | 2K | $0.00 | $0 | 4K |
| 2026-04-14 | Roe Kevin Charles | Director | Grant | 2K | $0.00 | $0 | 27K |
| 2026-04-14 | Raines William F III | Director | Grant | 2K | $0.00 | $0 | 14K |
| 2026-04-14 | Porter Jeffrey H | Director | Grant | 2K | $0.00 | $0 | 3K |
| 2025-12-17 | Crosnoe Clark R. | 10% owner | Sell | 19K | $2.34 | $45K | 18K |
| 2025-12-17 | Crosnoe Clark R. | 10% owner | Sell | 70K | $2.34 | $164K | 57K |
| 2025-12-17 | Crosnoe Clark R. | 10% owner | Sell | 462K | $2.31 | $1.1M | 361K |
| 2025-11-28 | Kennedy Thomas Ronan | CEO and CFO | Grant | 445K | price not stated in the filing | not stated | 514K |
| 2025-05-16 | Swift Sibyl Nichole | Director | Grant | 2K | $0.00 | $0 | 3K |
| 2025-05-16 | Stephen Scott G. | Director | Grant | 2K | $0.00 | $0 | 3K |
| 2025-05-16 | Sellers Bakari T. | Director | Grant | 2K | $0.00 | $0 | 3K |
| 2025-05-16 | Roe Kevin Charles | Director | Grant | 2K | $0.00 | $0 | 25K |
| 2025-05-16 | Raines William F III | Director | Grant | 2K | $0.00 | $0 | 12K |
| 2025-05-16 | Porter Jeffrey H | Director | Grant | 2K | $0.00 | $0 | 2K |
| 2025-05-06 | Roe Kevin Charles | Director | Conversion | 24K | price not stated in the filing | not stated | 24K |
| 2025-05-06 | Kennedy Thomas Ronan | CEO and CFO | Conversion | 68K | price not stated in the filing | not stated | 75K |
| 2025-05-06 | Porter Jeffrey H | Director | Conversion | 466K | price not stated in the filing | not stated | 466K |
| 2025-05-06 | Porter Jeffrey H | Director | Conversion | 41K | price not stated in the filing | not stated | 41K |
| 2025-05-06 | Porter Jeffrey H | Director | Conversion | 5K | price not stated in the filing | not stated | 5K |
| 2025-05-06 | Porter Jeffrey H | Director | Conversion | 62K | price not stated in the filing | not stated | 62K |
| 2024-08-23 | Raines William F III | Director | Grant | 75K | $0.00 | $0 | 84K |
| 2024-03-29 | Sellers Bakari T. | Director | Grant | 4K | $0.00 | $0 | 9K |
| 2024-03-29 | Raines William F III | Director | Grant | 4K | $0.00 | $0 | 9K |
| 2024-03-29 | Stephen Scott G. | Director | Grant | 4K | $0.00 | $0 | 10K |
| 2024-03-29 | Swift Sibyl Nichole | Director | Grant | 4K | $0.00 | $0 | 8K |
| 2024-01-11 | Coffman Raymond Scott | TenPercentOwner | Grant | 13K | price not stated in the filing | not stated | 388K |
| 2023-05-03 | Kennedy Thomas Ronan | Interim CEO and CFO | Buy | 5K | $2.10 | $11K | 6K |
| 2023-02-17 | Swift Sibyl Nichole | Director | Grant | 5K | $0.00 | $0 | 15K |
| 2023-02-17 | Stephen Scott G. | Director | Grant | 5K | $0.00 | $0 | 56K |
| 2023-02-17 | Sellers Bakari T. | Director | Grant | 5K | $0.00 | $0 | 18K |
| 2023-02-17 | Raines William F III | Director | Grant | 5K | $0.00 | $0 | 16K |
| 2022-08-09 | Swift Sibyl Nichole | Director | Grant | 5K | $0.00 | $0 | 10K |
| 2022-08-09 | Coffman Raymond Scott | Director,TenPercentOwner | Grant | 227K | price not stated in the filing | not stated | 16.9M |
| 2022-05-17 | Sumichrast Martin A. | Chairman, CEO | Grant | 41K | price not stated in the filing | not stated | 1.9M |
| 2022-05-17 | Coffman Raymond Scott | Director,TenPercentOwner | Grant | 301K | price not stated in the filing | not stated | 16.6M |
| 2022-05-16 | MacDermott Kevin | President | Grant | 125K | price not stated in the filing | not stated | 126K |
| 2022-03-11 | Sellers Bakari T. | Director | Grant | 5K | $0.00 | $0 | 13K |
| 2022-03-11 | Ghiloni Peter J. | Director | Grant | 5K | $0.00 | $0 | 310K |
| 2022-03-11 | Raines William F III | Director | Grant | 5K | $0.00 | $0 | 11K |
| 2022-03-11 | Stephen Scott G. | Director | Grant | 5K | $0.00 | $0 | 51K |
| 2022-02-28 | Sumichrast Martin A. | Chairman & CO-CEO | Grant | 40K | price not stated in the filing | not stated | 1.9M |
| 2022-02-28 | Coffman Raymond Scott | CO-CEO, President, Director | Grant | 292K | price not stated in the filing | not stated | 16.3M |
| 2022-01-01 | Sumichrast Martin A. | Chairman & CO-CEO | Exercise or conversion | 250K | price not stated in the filing | not stated | 250K |
| 2021-12-28 | Coffman Raymond Scott | CO-CEO, President, Director | Grant | 306K | price not stated in the filing | not stated | 16.0M |
| 2021-12-28 | Sumichrast Martin A. | Chairman & CO-CEO | Grant | 42K | price not stated in the filing | not stated | 1.6M |
| 2021-10-01 | Kennedy Thomas Ronan | CFO | Grant | 25K | $0.00 | $0 | 49K |
| 2021-10-01 | Kennedy Thomas Ronan | CFO | Exercise or conversion | 17K | price not stated in the filing | not stated | 24K |
| 2021-09-28 | Wiesehan John J III | Chief Revenue Officer | Other transaction | 162K | price not stated in the filing | not stated | 0 |
| 2021-09-28 | Wiesehan John J III | Chief Revenue Officer | Other transaction | 150K | price not stated in the filing | not stated | 176K |
| 2021-08-24 | Kennedy Thomas Ronan | CFO & COO | Buy | 7K | $2.04 | $15K | 7K |
| 2021-08-16 | Coffman Raymond Scott | CO-CEO, President, Director | Grant | 330K | price not stated in the filing | not stated | 15.7M |
| 2021-08-16 | Sumichrast Martin A. | Chairman & CO-CEO | Grant | 45K | price not stated in the filing | not stated | 1.5M |
| 2021-07-22 | Wiesehan John J III | Chief Revenue Officer | Buy | 162K | price not stated in the filing | not stated | 162K |
| 2021-05-14 | Coffman Raymond Scott | CO-CEO, President, Director | Grant | 369K | price not stated in the filing | not stated | 15.4M |
| 2021-05-14 | Sumichrast Martin A. | Chairman & CO-CEO | Grant | 51K | price not stated in the filing | not stated | 1.5M |
| 2021-03-12 | Raines William F III | Director | Grant | 5K | $0.00 | $0 | 6K |
| 2021-03-12 | Ghiloni Peter J. | Director | Grant | 5K | $0.00 | $0 | 305K |
| 2021-03-12 | Farar Sim | Director | Grant | 7K | $0.00 | $0 | 7K |
| 2021-03-12 | Sellers Bakari T. | Director | Grant | 5K | $0.00 | $0 | 8K |
| 2021-03-12 | Stephen Scott G. | Director | Grant | 5K | $0.00 | $0 | 46K |
| 2021-03-12 | Raines William F III | Director | Other transaction | 693K | $0.00 | $0 | 3.8M |
| 2021-03-11 | Sumichrast Martin A. | Chairman & CO-CEO | Sell | 65K | $3.93 | $257K | 1.4M |
| 2021-03-10 | Sumichrast Martin A. | Chairman & CO-CEO | Sell | 60K | $4.04 | $240K | 1.5M |
| 2021-03-08 | Coffman Raymond Scott | CO-CEO, President, Director | Grant | 2.2M | price not stated in the filing | not stated | 15.0M |
| 2021-03-08 | Sumichrast Martin A. | Chairman & CO-CEO | Grant | 301K | price not stated in the filing | not stated | 1.6M |
| 2021-03-02 | Raines William F III | Director | Sell | 20K | $4.04 | $81K | 1K |
| 2021-02-22 | Unknown | CO-CEO, President, Director | Sell | 122K | $4.25 | $519K | 0 |
| 2021-02-19 | Unknown | CO-CEO, President, Director | Sell | 3K | $4.28 | $13K | 122K |
| 2021-02-19 | Sumichrast Martin A. | Chairman & CO-CEO | Sell | 240K | $4.42 | $1.1M | 0 |
| 2021-02-18 | Sumichrast Martin A. | Chairman & CO-CEO | Sell | 113K | $4.43 | $501K | 240K |
| 2021-02-17 | Sumichrast Martin A. | Chairman & CO-CEO | Sell | 42K | $4.54 | $193K | 353K |
| 2020-12-20 | Raines William F III | Director | Other transaction | 2.2M | $0.00 | $0 | 4.5M |
| 2020-08-14 | Sellers Bakari T. | Director | Sell | 10K | $3.43 | $34K | 3K |
| 2020-04-23 | Raines William F III | Director | Other transaction | 6.6M | $0.00 | $0 | 6.7M |
| 2020-04-23 | SIEGEL SEYMOUR | Director | Other transaction | 6.6M | $0.00 | $0 | 3K |
| 2020-03-09 | Ghiloni Peter J. | Director | Buy | 25K | $0.75 | $19K | 300K |
| 2020-02-27 | Sumichrast Martin A. | CO-CEO | Other transaction | 462K | price not stated in the filing | not stated | 1.6M |
| 2020-02-27 | Coffman Raymond Scott | CO-CEO | Other transaction | 3.4M | price not stated in the filing | not stated | 12.9M |
| 2020-02-27 | Dunayer Caryn Nicole | President | Other transaction | 256K | price not stated in the filing | not stated | 994K |
| 2020-02-26 | Sumichrast Martin A. | CO-CEO | Other transaction | 788K | price not stated in the filing | not stated | 1.2M |
| 2020-02-26 | Coffman Raymond Scott | CO-CEO | Other transaction | 8.8M | price not stated in the filing | not stated | 3.8M |
| 2020-02-26 | Coffman Raymond Scott | CO-CEO | Other transaction | 5.7M | price not stated in the filing | not stated | 9.6M |
| 2020-02-26 | Dunayer Caryn Nicole | President | Other transaction | 438K | price not stated in the filing | not stated | 738K |
| 2020-01-27 | Elliott Mark S | CFO & COO | Buy | 5K | $1.06 | $5K | 52K |
| 2020-01-14 | Elliott Mark S | CFO & COO | Buy | 15K | $1.00 | $15K | 47K |
| 2020-01-14 | Sellers Bakari T. | Director | Buy | 10K | $1.00 | $10K | 13K |
| 2020-01-14 | Morris Gregory C | Director | Buy | 15K | $1.00 | $15K | 18K |
| 2020-01-14 | Stephen Scott G. | Director | Buy | 20K | $1.00 | $20K | 41K |
| 2020-01-14 | Raines William F III | Director | Buy | 20K | $1.00 | $20K | 114K |
| 2020-01-14 | Ghiloni Peter J. | Director | Buy | 125K | $1.00 | $125K | 275K |
| 2020-01-14 | Sumichrast Martin A. | CO-CEO | Buy | 125K | $1.00 | $125K | 396K |
| 2020-01-14 | Coffman Raymond Scott | CO-CEO | Buy | 125K | $1.00 | $125K | 12.6M |
| 2019-12-20 | SIEGEL SEYMOUR | Director | Other transaction | 2.2M | $0.00 | $0 | 6.6M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON1 Form 144 notice on file for YCBD worth $2.2M at the prices reported; 0 in the last 90 days worth $0. Latest: Clark R. Crosnoe, CRC Investment Fund LP, NM 2018 Trust dated April 4, 2018, AMC Legacy Trust dated December 21, 2012 filed on 2025-12-17 to sell 986,851 shares ($2.2M) from 2025-12-17.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2025-12-17 | Clark R. Crosnoe, CRC Investment Fund LP, NM 2018 Trust dated April 4, 2018, AMC Legacy Trust dated December 21, 2012Stockholder | 987K | $2.2M | 11.072% | 2025-12-17 | MAREX CAPITAL MARKETS INC. |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON1 holder reports 5% or more of YCBD in its latest filing, on Schedule 13D (active intent). The holder is Akretive Holdings LLC at 15.9% of the class (2,229,805 shares), filed 2026-11-04 for an event on 2026-10-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-11-04 | 13D | Akretive Holdings LLCother entity | 2.2M | 15.9% | 2026-10-30 |
| 2025-12-19 | 13G/Ano. 1 | Clark R. Crosnoeindividual | 436K | 4.9% | 2025-12-17 |
| 2025-12-19 | 13G/Ano. 1 | CRC Investment Fund LPcorporation | 361K | 4.1% | 2025-12-17 |
| 2025-12-19 | 13G/Ano. 1 | NM 2018 Trust dated April 4, 2018other entity | 57K | 0.6% | 2025-12-17 |
| 2025-12-19 | 13G/Ano. 1 | AMC Legacy Trust dated December 21, 2012other entity | 18K | 0.2% | 2025-12-17 |
13F holders
Tracked managers holding YCBD at their latest 13F. JSON1 of the 30 tracked managers held YCBD at their latest 13F, $42K in total at quarter-end prices. Citadel Advisors is the largest at $42K (0.0% of its portfolio) as of 2026-09-30. Over the prior quarter 1 added shares and 0 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-09-30 | 93K | $42K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
cbdMD in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows cbdMD (YCBD), SEC CIK 1644903, listed on NYSE, classified by the SEC as perfumes, cosmetics & other toilet preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-20.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-30.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2025-12-17.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-11-04.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-09-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2025-11-25.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-04-14.JSON and CSV
- Company record
- EDGAR filing index for CIK 1644903Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as perfumes, cosmetics & other toilet preparations
Other company pages
Datasets
Frequently Asked Questions
How much of YCBD is sold short?
What is YCBD's daily short volume?
Does YCBD have fails to deliver?
Are YCBD insiders buying or selling?
Have YCBD insiders filed to sell?
Who owns 5% or more of YCBD?
Which tracked 13F managers own YCBD?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.